Neuphoria Therapeutics Inc. — All Filings
408 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
12G3-2B
15-12G
20-F
20-F/A
3
4
4/A
424B3
424B4
424B5
6-K
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DFRN14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-6
NT 10-Q
POS AM
PRE 14A
PREC14A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SUPPL
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0000950170-25-075175 | May 20, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-045970 | May 20, 2025 | — |
| 4/A | — | 0001213900-25-045445 | May 19, 2025 | Apr 16, 2025 |
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-25-044176 | May 15, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-033144 | Apr 18, 2025 | Apr 16, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-033142 | Apr 18, 2025 | Apr 16, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-033143 | Apr 18, 2025 | Apr 16, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-033139 | Apr 18, 2025 | Apr 16, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-033140 | Apr 18, 2025 | Apr 16, 2025 |
| 10-Q | 10-Q | 0000950170-25-020473 | Feb 14, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001172661-25-001246 | Feb 14, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-012481 | Feb 12, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-009546 | Feb 4, 2025 | — |
| EFFECT | — | 9999999995-25-000236 | Jan 29, 2025 | — |
| UPLOAD | — | 0000000000-25-000888 | Jan 28, 2025 | — |
| CORRESP | — | 0001213900-25-007464 | Jan 28, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-009848 | Jan 28, 2025 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-007152 | Jan 28, 2025 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-25-006517 | Jan 24, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-003492 | Jan 14, 2025 | Jan 10, 2025 |
| EFFECT | — | 9999999995-25-000061 | Jan 8, 2025 | — |
| CORRESP | — | 0001213900-25-001693 | Jan 7, 2025 | — |
| S-3/A | AMENDMENT NO. 2 TO FORM S-3 | 0001213900-25-001360 | Jan 7, 2025 | — |
| EFFECT | — | 9999999995-24-003926 | Dec 27, 2024 | — |
| EFFECT | — | 9999999995-24-003928 | Dec 27, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | 0001213900-24-112003 | Dec 23, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-112016 | Dec 23, 2024 | — |
| 15-12G | FORM 15-12G | 0001213900-24-111979 | Dec 23, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-24-111996 | Dec 23, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-109347 | Dec 16, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-108436 | Dec 12, 2024 | Dec 11, 2024 |
| S-3/A | AMENDMENT NO. 1 TO FORM S-3 | 0001213900-24-102200 | Nov 25, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-100971 | Nov 21, 2024 | Nov 18, 2024 |
| UPLOAD | — | 0000000000-24-012961 | Nov 21, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-099678 | Nov 18, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-127032 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | BIONOMICS LIMITED | 0000902664-24-006517 | Nov 14, 2024 | — |
| SC 13G | — | 0001172661-24-005076 | Nov 14, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-097547 | Nov 13, 2024 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-24-096782 | Nov 12, 2024 | Dec 11, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-095926 | Nov 8, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-086918 | Oct 10, 2024 | Oct 9, 2024 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-24-086406 | Oct 9, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-233941 | Oct 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-084175 | Oct 2, 2024 | Oct 1, 2024 |
| 10-K | ANNUAL REPORT | 0001213900-24-082909 | Sep 30, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-061529 | Jul 16, 2024 | Jul 11, 2024 |
| 3 | — | 0001213900-24-061135 | Jul 12, 2024 | Jul 1, 2024 |
| 3 | — | 0001213900-24-059644 | Jul 8, 2024 | Jul 1, 2024 |
| 3 | — | 0001213900-24-059647 | Jul 8, 2024 | Jul 1, 2024 |